NasdaqGM - Delayed Quote
USD
Omeros Corporation (OMER)
17.30
-0.25
(-1.42%)
At close: 4:00:00 PM EST
17.30
+0.01
(+0.06%)
After hours: 4:01:09 PM EST
Trade Omeros on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutOmeros will report third-quarter 2026 results after the market closes on November 16, followed by a management conference call. The company’s main commercial drug, YARTEMLEA, faces a second European regulatory rejection, while early U.S. sales and reimbursement support remain central to the investment outlook. As of November 10, OMER was down 1.42% on the regular session plus after-hours trading.
